The Impact of Shunt Type on Palliative Outcomes in Neonates and Infants With Diminished Pulmonary Blood Flow

World Journal for Pediatric and Congenital Heart Surgery

Volumn 2, Issue 1, 2011, Pages 80-84

  Samson Von, Patrick ^a   Tatge, Lena ^a   Gottschalk, Urda ^a   Müller, Götz C ^a   Reichenspurner, Hermann ^a   Dodge Khatami, Ali ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

congenital heart disease (CHD); outcomes; systemic pulmonary artery shunts

Indexed keywords

EID: 84990348160     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135110387167     Document Type: Article

References (15)

1. Donahoo JS Gardner TJ Zakha K. Systemic-pulmonary shunts in neonates and infants using micorporous expanded polytetrafluoroethylene: immediate and late results. Ann Thorac Surg. 1980; 30: 146–150.
2. Bove EL Kohman L Sereika S, et al. The modified Blalock-Taussig shunt: analysis of adequacy and duration of palliation. Circulation. 1987; 76(Supplement III):19–23.
3. Ishikawa S Takahashi T Sato Y, et al. Growth of the pulmonary arteries after systemic-pulmonary shunt. Ann Thorac Cardiovasc Surg. 2001; 7: 337–340.
4. Jahangiri M Lincoln C Shinebourne EA. Does the modified Blalock-Taussig shunt cause growth of the contralateral pulmonary artery?. Ann Thorac Surg. 1999; 67: 1397–1399.
5. Lawless CE Smith EEJ Hallidie-Smith K Sapsford RN. The modified Blalock-Taussig shunt using micorporous expanded polytetrafluoroethylene (PTFE). J Thorac Cardiovasc Surg. 1982; 23: 287–292.
6. Tamisier D Vouhe PR Vernant F Leca F Massot C Neveux JY. Modified Blalock-Taussig shunts: results in infants less than 3 months of age. Ann Thorac Surg. 1990; 49: 797–801.
7. Ibawi MN Grieco J DeLeon SY, et al. Modified Blalock-Taussig shunt in newborn infants. J Thoracic Cardiovasc Surg. 1984; 88: 770–775.
8. Gladman G McCrindle BW Williams WG Freedom RM Benson LN. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the current era. J Thorac Cardiovasc Surg. 1997; 114: 25–30.
9. Wernovsky G Wypij D Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995; 92: 2226–2235.
10. de Leval MR McKay R Jones M Stark J Macartney FJ, Modified Blalock-Taussig shunt: use of subclavian artery orifice as flow regulator in prosthetic systemic to pulmonary artery shunts. J Thorac Cardiovasc Surg. 1981; 81: 112–119.
11. Mohammadi S Benhameid O Campbell A, et al. Could we still improve early and interim outcome after prosthetic systemic-pulmonary shunt? A risk factors analysis. Eur J Cardiothorac Surg. 2008; 34: 545–549.
12. Amato JJ Marbey ML Bush C Galdieri RJ Cotroneo JV Bushong J. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease: revival of the central shunt. J Thorac Cardiovasc Surg. 1988; 95: 62–69.
13. Godart F Qureshi SA Simha A, et al. Effects of modified and classical Blalock-Taussig shunts on the pulmonary arterial tree. Ann Thorac Surg. 1998; 66: 512–518.
14. Stewart S Alexson C Manning J Oakes D Eberly SW. Long-term palliation with the classic Blalock-Taussig shunt. J Thorac Cardiovasc Surg. 1988; 96: 117–121.
15. Potapov EV Alexi-Meskishvili VV Dähnert I Ivanitskaia EA Lange PE Hetzer R. Development of pulmonary arteries after central aortopulmonary shunt in newborns. Ann Thorac Surg. 2001; 71: 899–906.